Meridian Wealth Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Meridian Wealth Management’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-49,600	Closed	-$169K	–	205
2018 Q3	$169K	Hold	49,600	–	–	0.07%	166
2018 Q2	$186K	Hold	49,600	–	–	0.09%	179
2018 Q1	$203K	Buy	+49,600	New	+$231K	0.1%	171

Meridian Wealth Management's KERX Position: Q4 2018 in Review

Meridian Wealth Management sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 49,600 shares — an estimated $169K sold.

Meridian Wealth Management first reported a position in KERX in Q1 2018 and held it in 3 quarters. The position peaked at $203K in Q1 2018. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

Meridian Wealth Management reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
Meridian Wealth Management sold 49,600 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $169K.
Meridian Wealth Management first reported a position in Keryx Biopharmaceuticals Inc in Q1 2018 and held it in 3 quarters.
Meridian Wealth Management's Keryx Biopharmaceuticals Inc position peaked at $203K in Q1 2018.
1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Meridian Wealth Management's 13F filing for Q4 2018, filed 5 Feb 2019.